Company Profile
Public information reviewedenGene Therapeutics Inc.
Operating through its subsidiary, enGene, Inc., enGene Holdings Inc. functions as a clinical-stage biotechnology firm.
USNASDAQ: ENGN
Follow
More
- Public sources
- 1 reviewed
- Published leadership records
- 6
- Last reviewed
- Sep 13, 2026

